Oliver Szolar | PhD



Oliver Szolar has worked in research and the pharmaceutical industry for 14 years. Previously, he held the position of the CSO at onepharm. Prior to that, he was head of analytical operations at onepharm and Aphton/Igeneon, Austria, after heading the instrumental analysis at the IFA, Department for Environmental Biotechnology, Austria. He holds a PhD in biotechnology from the University of Natural Resources and Life Sciences, Vienna, Austria.


Helmut H. Buschmann | PhD



Helmut H. Buschmann is a senior management executive with 19 years of international experience in drug discovery research and drug development in the pharmaceutical and biotechnology industry. Helmut Buschmann spent 10 years with Grünenthal (Aachen) before joining Laboratorios Dr. Esteve in Barcelona as research director for 7 years. In 2009, he joined Pharma Consulting Aachen as independent consultant for diverse companies. Under his guidance, more than 15 NCEs entered clinical development with some of them reaching clinical phase III and the market (e.g. Tapentadol marketed as Nucynta® in the U.S. and as Palexia® in Europe). Helmut Buschmann led or co-authored more than 90 publications in the field, edited and authored three books, and is listed as inventor in more than 180 patent applications. Moreover, he is member of several scientific advisory boards of public research institutions in Europe and gives lectures at the universities of Aachen and Rostock.